The Peptide Synthesis Market is being driven by Burgeoning therapeutic pipeline and commercial success of peptide drugs
The Peptide Synthesis Market is expected to grow at a CAGR of 8.1% during 2024 and 2029. During this period, the market is also expected to show a growth of USD 469.9 million. The global peptide synthesis market is witnessing a significant trend towards the adoption of green chemistry and sustainable manufacturing practices. This shift is no longer merely a corporate social responsibility concern, but a business necessity, fueled by increasing regulatory pressures, client demands, and the long-term economic advantages of sustainability. Traditional peptide synthesis methods, such as Solid Phase Peptide Synthesis (SPPS), have long relied on substantial quantities of petroleum-derived organic solvents, including N,N-dimethylformamide (DMF) and dichloromethane (DCM), which present both environmental and health concerns. The industry now stands at a critical juncture, necessitating a fundamental overhaul of these entrenched processes.
Get more information on Peptide Synthesis Market by requesting a sample report
The market is segmented based on
According to Technavio, There are several factors that are causing the market to flourish during the forecast period, which are as follows:
However, the market also witnesses some limitations, which are as follows:
Rich Experience: 20+ years leading global market research, trusted insights across industries.
Unlock Business Potential with Technavio: Maximize ROI with Technavio's tailored market research: deep dives and actionable insights.
Your Guide to Market Success: Empower your business with Technavio's market research and future-proof your decisions.
Market Scope |
|
Report Coverage |
Details |
Page number |
228 |
Base year |
2024 |
Historic period |
2019-2023 |
Forecast period |
2025-2029 |
Growth momentum & CAGR |
Accelerate at a CAGR of 8.1% |
Market growth 2025-2029 |
USD 469.9 million |
Market structure |
fragmentation |
YoY growth 2024-2025(%) |
7.5 |
Key countries |
US, Germany, China, UK, Canada, Japan, France, India, Australia, and South Korea |
Competitive landscape |
Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks |
Find out which segment is leading the market by accessing the free PDF report
The Peptide Synthesis Market encompasses various aspects of peptide production, including optimization of SPS conditions, formation of peptide bonds, assessment of synthesis yield and peptide purity, characterization techniques, stability studies, formulation development, delivery systems, modifications, and analog creation. Proteolytic stability, immunogenicity prediction, peptide-drug conjugates, therapeutic and diagnostic peptides, research peptides, custom design, cost, and time are also significant factors. Process analytical technology, in-line monitoring, quality control, sequencing via MS, peptide mapping, HPLC purity assessment, and impurity profiling are essential analytical methods.
The solid-phase peptide synthesis market encompasses the sales revenue of healthcare applications and IT systems, as well as Internet-based healthcare tools, telehealth technologies, and digital health technologies to healthcare providers and businesses. According to Technavio, the global healthcare market size is determined by the combined revenue generated by manufacturers and providers of equipment, supplies, pharmaceuticals, biotechnology, healthcare technology players, and life sciences tools and services. The expansion of the healthcare technology market is influenced by factors affecting both the healthcare industry and IT spending market. Key drivers include the continuous need to decrease costs for healthcare providers in both developed and emerging economies. This pressure to reduce expenses is a significant challenge faced by companies in the healthcare sector. Solid-phase peptide synthesis techniques, such as those utilizing fmoc chemistry and t-boc strategy, are essential tools in the production of peptides for various healthcare applications.. Industries are leveraging the products belonging to the market for customer engagement, transactional notifications, and promotional offers.
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/
Safe and Secure SSL Encrypted